V LANSCHOT KEMPEN/ NL0000302636 /
- - | Chg. - | Volume | Bid03:00:58 | Ask03:00:58 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.950EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 1.57 bill.EUR | 5.41% | 13.10 |
GlobeNewswire
04/03
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire
29/02
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire
22/12/2023
Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire
10/10/2023
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
euro adhoc
09/09/2021
EANS-News: Atrium European Real Estate Limited / Publication of Scrip Dividend Circular Q3 2021 CNE
euro adhoc
09/06/2021
EANS-News: Atrium European Real Estate Limited / Publication of Scrip Dividend Circular Q2 2021 CNE
GlobeNewswire
09/02/2021
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire
26/06/2020
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire
24/06/2020
Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire
19/06/2020
Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire
18/06/2020
Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire
17/06/2020
Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire
03/06/2020
Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire
22/01/2020
Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement